2.30
price down icon3.36%   -0.08
 
loading
Schlusskurs vom Vortag:
$2.38
Offen:
$2.315
24-Stunden-Volumen:
5,822
Relative Volume:
0.00
Marktkapitalisierung:
$15.88M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.72M
KGV:
-0.8714
EPS:
-2.6394
Netto-Cashflow:
$-6.25M
1W Leistung:
+1.72%
1M Leistung:
-8.00%
6M Leistung:
-38.83%
1J Leistung:
-47.49%
1-Tages-Spanne:
Value
$2.30
$2.38
1-Wochen-Bereich:
Value
$2.24
$2.38
52-Wochen-Spanne:
Value
$1.55
$5.59

Edesa Biotech Inc Stock (EDSA) Company Profile

Name
Firmenname
Edesa Biotech Inc
Name
Telefon
(905) 475-1234
Name
Adresse
100 SPY COURT, MARKHAM, ON
Name
Mitarbeiter
16
Name
Twitter
@EdesaBiotech
Name
Nächster Verdiensttermin
2024-08-12
Name
Neueste SEC-Einreichungen
Name
EDSA's Discussions on Twitter

Vergleichen Sie EDSA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
EDSA
Edesa Biotech Inc
2.30 15.88M 0 -7.72M -6.25M -2.6394
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
489.42 128.67B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
585.35 60.99B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
599.91 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
236.34 29.89B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
253.34 26.16B 3.81B -644.79M -669.77M -6.24

Edesa Biotech Inc Aktie (EDSA) Neueste Nachrichten

pulisher
Apr 15, 2025

Healthcare Veteran Returns to NeuPath as President, Armed with Ambitious Expansion Plan - Stock Titan

Apr 15, 2025
pulisher
Apr 13, 2025

Edesa Biotech secures $15 million for clinical program - MSN

Apr 13, 2025
pulisher
Apr 05, 2025

Edesa Biotech (NASDAQ:EDSA) and Earth Science Tech (OTCMKTS:ETST) Head-To-Head Review - Defense World

Apr 05, 2025
pulisher
Apr 05, 2025

Edesa Biotech says Peter Weiler to succeed Stephen Lemieux as CFO - MSN

Apr 05, 2025
pulisher
Apr 05, 2025

Nuvectis Pharma (NASDAQ:NVCT) and Edesa Biotech (NASDAQ:EDSA) Critical Analysis - Defense World

Apr 05, 2025
pulisher
Apr 05, 2025

Edesa Biotech Announces Chief Financial Officer Transition - GlobeNewswire

Apr 05, 2025
pulisher
Apr 04, 2025

Edesa Biotech announces CFO transition - MSN

Apr 04, 2025
pulisher
Apr 04, 2025

Edesa Biotech names Peter Weiler as new CFO By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

Edesa Biotech (EDSA) Shares Drop After New CFO Announcement - GuruFocus

Apr 04, 2025
pulisher
Apr 04, 2025

Edesa Biotech Appoints New CFO Amid Leadership Change - TipRanks

Apr 04, 2025
pulisher
Apr 04, 2025

Edesa Biotech names Peter Weiler as new CFO - Investing.com

Apr 04, 2025
pulisher
Apr 04, 2025

Edesa Biotech Hires Peter Weiler From Exzell Pharma to be New CFO - marketscreener.com

Apr 04, 2025
pulisher
Apr 04, 2025

Edesa Biotech, Inc. Announces Chief Financial Officer Changes, Effective May 1, 2025 - MarketScreener

Apr 04, 2025
pulisher
Mar 17, 2025

HC Wainwright Comments on Edesa Biotech Q2 Earnings - Defense World

Mar 17, 2025
pulisher
Mar 15, 2025

HC Wainwright Reiterates “Buy” Rating for Edesa Biotech (NASDAQ:EDSA) - Defense World

Mar 15, 2025
pulisher
Mar 13, 2025

H.C. Wainwright maintains $21 target on Edesa Biotech shares By Investing.com - Investing.com Australia

Mar 13, 2025
pulisher
Mar 13, 2025

H.C. Wainwright maintains $21 target on Edesa Biotech shares - Investing.com India

Mar 13, 2025
pulisher
Mar 11, 2025

Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential - The Globe and Mail

Mar 11, 2025
pulisher
Mar 07, 2025

Edesa Biotech completes US$15 million private placement - Fasken

Mar 07, 2025
pulisher
Mar 07, 2025

You Won't Believe What Nvidia CEO Jensen Huang Just Said - The Globe and Mail

Mar 07, 2025
pulisher
Mar 06, 2025

Edesa Biotech files to sell 7.81M common shares for holders - MSN

Mar 06, 2025
pulisher
Mar 06, 2025

Nvidia Stock Isn’t So Magnificent Anymore. Is It Time to Sell Shares Now? - The Globe and Mail

Mar 06, 2025
pulisher
Mar 06, 2025

Zacks Small Cap Boosts Earnings Estimates for Edesa Biotech - Defense World

Mar 06, 2025
pulisher
Mar 03, 2025

EDSA: Raises 15 Million to Advance EB06 - Smartkarma

Mar 03, 2025
pulisher
Mar 03, 2025

EDSA: Raises $15 Million to Advance EB06… - Yahoo Finance

Mar 03, 2025
pulisher
Feb 17, 2025

Biotech Stocks To Keep An Eye OnFebruary 13th - MarketBeat

Feb 17, 2025
pulisher
Feb 15, 2025

Biotech Stocks To Keep An Eye On – February 13th - Defense World

Feb 15, 2025
pulisher
Feb 14, 2025

Edesa Biotech Reports Fiscal 1st Quarter 2025 Results - GlobeNewswire

Feb 14, 2025
pulisher
Feb 14, 2025

Edesa Biotech Advances Vitiligo Treatment Amidst Solid Financial Backing - TipRanks

Feb 14, 2025
pulisher
Feb 14, 2025

Edesa Biotech Inc. (EDSA) reports earnings - Quartz

Feb 14, 2025
pulisher
Feb 14, 2025

Edesa Biotech Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 14, 2025
pulisher
Feb 14, 2025

Edesa Biotech, Inc. SEC 10-Q Report - TradingView

Feb 14, 2025
pulisher
Feb 14, 2025

Edesa Biotech Reports Q1 2025 Financial Results and Updates on EB06 Development for Vitiligo Treatment - Nasdaq

Feb 14, 2025
pulisher
Feb 14, 2025

Edesa's Q1 Report Reveals Major Vitiligo Drug Progress: $15M Cash Injection Fuels FDA Push - StockTitan

Feb 14, 2025
pulisher
Feb 14, 2025

US Penny Stocks To Watch In February 2025 - Simply Wall St

Feb 14, 2025
pulisher
Feb 14, 2025

Edesa Biotech secures $15 million for clinical program By Investing.com - Investing.com Nigeria

Feb 14, 2025
pulisher
Feb 13, 2025

Novartis to acquire Anthos Therapeutics for up to $3.1 billion - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Edesa Biotech, Inc. announced that it has received $14.999992 million in funding from Velan Capital Investment Management LP and another investor - Marketscreener.com

Feb 13, 2025
pulisher
Feb 13, 2025

H: Riding the Market Waves of Growth and Decline in 2023 - The InvestChronicle

Feb 13, 2025
pulisher
Feb 13, 2025

Edesa Biotech Inc (EDSA) Stock: A Comprehensive 52-Week Review - The InvestChronicle

Feb 13, 2025
pulisher
Feb 13, 2025

Dow Jumps Over 100 Points; Deere Posts Upbeat Earnings - Benzinga

Feb 13, 2025
pulisher
Feb 13, 2025

Stock market news: Moleculin Biotech +583.33%, Cloudastructure +105.68% among top gainers during midday trading - Business Upturn

Feb 13, 2025
pulisher
Feb 13, 2025

Nasdaq Surges 150 Points; Cisco Earnings Top Views - Benzinga

Feb 13, 2025
pulisher
Feb 13, 2025

Edesa Biotech shares jump on $15M private placement - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Edesa Biotech (EDSA) Sees Sharp Stock Increase After Equity News - Stocks Telegraph

Feb 13, 2025
pulisher
Feb 13, 2025

Stock market today: Moleculin Biotech +388.10%, Alpha Modus Holdings +156.52% among top gainers in early trading - Business Upturn

Feb 13, 2025
pulisher
Feb 13, 2025

MAXONA Pharmaceuticals Completes Phase 1 Trials for Breakthrough Pain Therapy - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

US Stocks Edge Higher; Producer Prices Increase In January - Benzinga

Feb 13, 2025

Finanzdaten der Edesa Biotech Inc-Aktie (EDSA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$19.80
price down icon 1.75%
$70.30
price up icon 2.22%
$32.51
price up icon 0.87%
$26.24
price up icon 1.84%
$102.53
price down icon 0.01%
biotechnology ONC
$248.35
price up icon 8.46%
Kapitalisierung:     |  Volumen (24h):